9VUU image
Deposition Date 2025-07-14
Release Date 2026-02-18
Last Version Date 2026-03-18
Entry Detail
PDB ID:
9VUU
Keywords:
Title:
Crystal structure of SADS-CoV main protease (Lys35Val) in complex with 27h
Biological Source:
Source Organism(s):
Expression System(s):
Method Details:
Experimental Method:
Resolution:
2.40 Å
R-Value Free:
0.22
R-Value Work:
0.16
R-Value Observed:
0.17
Space Group:
C 1 2 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:ORF1ab polyprotein
Gene (Uniprot):orf1ab
Mutagens:K35V
Chain IDs:A, B
Chain Length:302
Number of Molecules:2
Biological Source:Swine acute diarrhea syndrome coronavirus
Ligand Molecules
Primary Citation
An intrinsic loop-mediated structural stability modulating inhibitor potency in the SADS-CoV and SARS-CoV-2 main proteases.
PLoS Pathog. 22 e1013981 e1013981 (2026)
PMID: 41734227 DOI: 10.1371/journal.ppat.1013981

Abstact

Swine acute diarrhea syndrome coronavirus (SADS-CoV) poses a significant zoonotic risk. The absence of the structure of SADS-CoV main protease (Mpro) severely impedes the development of effective antiviral therapeutics. Here, we present the high-resolution structures of SADS-CoV Mpro and its complexes with inhibitors 27h and SY110, respectively. These two compounds inhibit SADS-CoV Mpro through a novel inhibition mechanism. Residues 40-53 of SADS-CoV Mpro adopt a single-helix conformation, in contrast to a coiled coil formed by two consecutive alpha-helices observed in SARS-CoV-2 Mpro. These structural differences contribute to the varying inhibitor potency between Alphacoronavirus (alpha-CoV) and Betacoronavirus (beta-CoV) Mpros. We subsequently demonstrate that the absence of residue '51' in alpha-CoV Mpros plays a key role in these conformational changes. Furthermore, 27h was proved to efficiently suppress SADS-CoV replication in both cell-based assays and porcine intestinal organoids-marking the first such assessment. Overall, these findings reveal that intrinsic Mpro dynamics influence inhibitor potency and provide insights for designing broad-spectrum Mpro inhibitors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback